Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis
Liangyou Rui, Jiandie D. Lin
Annual Review of Nutrition (2022) Vol. 42, Iss. 1, pp. 91-113
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The AMPK pathway in fatty liver disease
Chunqiu Fang, Jianheng Pan, Ning Qu, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 170
Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment
Peng Zhang, Zhimin Chen, Henry Kuang, et al.
Cell Metabolism (2022) Vol. 34, Iss. 9, pp. 1359-1376.e7
Open Access | Times Cited: 57
AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression
Ilitch Aquino Marcondes‐de‐Castro, Pedro H. Reis‐Barbosa, Thatiany de Souza Marinho, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 11, pp. 1868-1876
Open Access | Times Cited: 24
Vicious Cycle‐Breaking Lipid Nanoparticles Remodeling Multicellular Crosstalk to Reverse Liver Fibrosis
Lingfeng Zhang, Wen‐Qi Deng, Qing‐Wen Huang, et al.
Advanced Materials (2024) Vol. 36, Iss. 16
Closed Access | Times Cited: 13
Envisioning how to advance the MASH field
Alina M. Allen, Zobair M. Younossi, Anna Mae Diehl, et al.
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 12
Endpoints in NASH Clinical Trials: Are We Blind in One Eye?
Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 40-40
Open Access | Times Cited: 11
Hepatic danger signaling triggers TREM2 + macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation
Linkang Zhou, Xiaoxue Qiu, Ziyi Meng, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 738
Closed Access | Times Cited: 9
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13320-13320
Open Access | Times Cited: 36
Glycolysis in Chronic Liver Diseases: Mechanistic Insights and Therapeutic Opportunities
Hengdong Qu, Junli Liu, Di Zhang, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1930-1930
Open Access | Times Cited: 16
Hepatic Snai1 and Snai2 promote liver regeneration and suppress liver fibrosis in mice
Pingping Wang, Qianqian Kang, Wenshu Wu, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113875-113875
Open Access | Times Cited: 6
MAP17 is a Novel NASH Progression Biomarker Associated with Macrophage Infiltration, Immunotherapy Response, and Oxidative Stress
Zhiwei Huang, Jiatong Chen, Shenglu Liu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 601-619
Open Access
Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases
Yuming Lu, Yifan Wang, Tao Ruan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ebastine-mediated destabilization of E3 ligase MKRN1 protects against metabolic dysfunction-associated steatohepatitis
Seungyeon Kim, Hyun-Ji Han, Hyunjin Rho, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Liver cirrhosis: molecular mechanisms and therapeutic interventions
Zihe Dong, Yeying Wang, Weilin Jin
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 4
Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy
Gang� Li, Xin Li, Iqbal Mahmud, et al.
JCI Insight (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 19
Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms
Simonetta Lugari, Enrica Baldelli, Amedeo Lonardo
Metabolism and Target Organ Damage (2023) Vol. 3, Iss. 1, pp. 5-5
Open Access | Times Cited: 10
Loss-of-function G6PD variant moderated high fat diet-induced obesity, adipocyte hypertrophy, and fatty liver in male rats
Shun Matsumura, Christina Signoretti, Samuel Fatehi, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 7, pp. 107460-107460
Open Access | Times Cited: 3
Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease
Xiaolei Fang, Jiayu Song, Kaixuan Zhou, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5645-5645
Open Access | Times Cited: 9
Moringa oleifera L. mediated zinc oxide nano-biofertilizer alleviates non-alcoholic steatohepatitis via modulating de novo lipogenesis pathway and miRNA-122 expression
Dina Mostafa Mohammed, Maha B. Salem, Mohamed Elzallat, et al.
Food Bioscience (2024) Vol. 60, pp. 104286-104286
Closed Access | Times Cited: 2
Extra-hepatic cancers in metabolic fatty liver syndromes
Amedeo Lonardo
(2023), pp. 11-17
Open Access | Times Cited: 6
Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease
Јannis Kountouras, Evangelos Kazakos, Stergios A. Pοlyzos, et al.
Clinical Immunology (2023) Vol. 256, pp. 109776-109776
Closed Access | Times Cited: 6
A bibliometric and visualized analysis of liver fibrosis from 2002 to 2022
Qianqian Zhao, Luhua Liang, Fei Zhai, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 38, Iss. 3, pp. 359-369
Closed Access | Times Cited: 8
From NAFLD to HCC: Advances in noninvasive diagnosis
Qinchen Xu, Maoxiao Feng, Yidan Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115028-115028
Open Access | Times Cited: 4
Time course of western diet (WD) induced nonalcoholic steatohepatitis (NASH) in female and male Ldlr-/- mice
Melinda H. Spooner, Manuel García‐Jaramillo, K. Denise Apperson, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0292432-e0292432
Open Access | Times Cited: 3
Human hepatocytes response to pathological shifts in liver fibrosis
Chrysanthus Chukwuma
The Journal of Medical Research (2024) Vol. 10, Iss. 1, pp. 37-41
Open Access
Page 1 - Next Page

Scroll to top